Forte Biosciences, Inc.
NASDAQ:FBRX · NASDAQ Capital Market
+$0.16 today
Vol 0.17M · Avg 0.30M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+38.53%
Period High
$35.53
Period Low
$9.45
Latest
$17.15
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Elicio Therapeutics, Inc.
NASDAQ:ELTX
$283.43M
Fate Therapeutics, Inc.
NASDAQ:FATE
$240.11M
Nkarta, Inc.
NASDAQ:NKTX
$204.62M
Alector, Inc.
NASDAQ:ALEC
$169.87M
Molecular Partners AG
NASDAQ:MOLN
$154.17M
Cardiff Oncology, Inc.
NASDAQ:CRDF
$105.29M
Corbus Pharmaceuticals Holdings, Inc.
NASDAQ:CRBP
$102.67M
PepGen Inc.
NASDAQ:PEPG
$101.68M
Actuate Therapeutics Inc
ACTU
$48.33M
Applied Therapeutics, Inc.
APLT
$14.86M
What is the latest FBRX filing?
The latest filing shown is EFFECT dated Jun 10, 2026.
How many recent filings does FBRX have?
Intrinsic Alpha currently shows 20 recent filings for FBRX.
Explore More
Continue the stock analysis
Jump to another research area for this company.